inside the promptly evolving field of cancer therapeutics, being familiar with the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is critical for creating effective solutions. One of the more promising techniques is using in vitro bystander outcome assays, which Perform a pivotal part in enhancing therapeutic efficacy. These assays, provid